C9293

Category

C. Outpatient PPS, temporary

NDC crosswalk

None in the loaded CMS ASP file

CMS HCPCS quarterly update

These sit next to C9293 in the CMS Level II file. All C codes

• C9254Injection, lacosamide, 1 mg
• C9257Injection, bevacizumab, 0.25 mg
• C9275Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose
• C9285Lidocaine 70 mg/tetracaine 70 mg, per patch
• C9290Injection, bupivacaine liposome, 1 mg
• C9300Injection, indigotindisulfonate sodium, 1 mg
• C9301Obecabtagene autoleucel, up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
• C9302Injection, zanidatamab-hrii, 2 mg
• C9303Injection, zolbetuximab-clzb, 1 mg
• C9304Injection, marstacimab-hncq, 0.5 mg